Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

BACKGROUND Endoscopic oesophageal changes are diagnostically helpful and identify patients exposed to the risk of disease chronicity. However, there is a serious lack of agreement about how to describe and classify the appearance of reflux oesophagitis AIMS To examine the reliability of criteria that describe the circumferential extent of mucosal breaks and to evaluate the functional and clinical correlates of patients with reflux disease whose oesophagitis was graded according to the Los Angeles system. METHODS Forty six endoscopists from different countries used a detailed worksheet to evaluate endoscopic video recordings from 22 patients with the full range of severity of reflux oesophagitis. In separate studies, Los Angeles system gradings were correlated with 24 hour oesophageal pH monitoring (178 patients), and with clinical trials of omeprazole treatment (277 patients). RESULTS Evaluation of circumferential extent of oesophagitis by the criterion of whether mucosal breaks extended between the tops of mucosal folds, gave acceptable agreement (mean κ value 0.4) among observers. This approach is used in the Los Angeles system. An alternative approach of grouping the circumferential extent of mucosal breaks as occupying 0–25%, 26–50%, 51–75%, 76–99%, or 100% of the oesophageal circumference, gave unacceptably high interobserver variation (mean κ values 0–0.15) for all but the lowest category of extent (mean κ value 0.4). Severity of oesophageal acid exposure was significantly (p<0.001) related to the severity grade of oesophagitis. Preteatment oesophagitis grades A–C were related to heartburn severity (p<0.01), outcomes of omeprazole (10 mg daily) treatment (p<0.01), and the risk for symptom relapse off therapy over six months (p<0.05). CONCLUSIONS Results add further support to previous studies for the clinical utility of the Los Angeles system for endoscopic grading of oesophagitis.

[1]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[2]  M. Savary,et al.  The esophagus : handbook and atlas of endoscopy , 1978 .

[3]  D. Hopwood,et al.  Reflux oesophagitis. , 1981, Clinics in gastroenterology.

[4]  A. Blum,et al.  Healing and relapse of reflux esophagitis during treatment with ranitidine. , 1986, Gastroenterology.

[5]  G. Danovitch,et al.  Liver transplantation today. , 1986, Annals of internal medicine.

[6]  J. Dent,et al.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole. , 1988, Gastroenterology.

[7]  L. Lundell,et al.  Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. , 1988, Scandinavian journal of gastroenterology.

[8]  F. Pace,et al.  Natural history of gastro-oesophageal reflux disease without oesophagitis. , 1991, Gut.

[9]  遠藤 光夫,et al.  Endoscopic staining in early diagnosis of esophageal cancer , 1991 .

[10]  G. Tytgat,et al.  Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. , 1992, Scandinavian journal of gastroenterology.

[11]  L. Lundell.  Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus. , 1992, Digestion.

[12]  A. Klauser,et al.  Three year follow up of patients with gastrooesophageal reflux disease. , 1992, Gut.

[13]  S. Spechler.  Epidemiology and natural history of gastro-oesophageal reflux disease. , 1992, Digestion.

[14]  A. Blum,et al.  Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? , 1992, Hepato-gastroenterology.

[15]  L. Demling.  Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? , 1992 .

[16]  A. Silman,et al.  Statistical methods for assessing observer variability in clinical measures. , 1992, BMJ.

[17]  T. Havelund,et al.  Interobserver variation in the endoscopic diagnosis of reflux esophagitis. , 1993, Scandinavian journal of gastroenterology.

[18]  J. Dent,et al.  Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. , 1994, Gut.

[19]  L. Lundell.  Long-term treatment of gastro-oesophageal reflux disease with omeprazole. , 1994, Scandinavian journal of gastroenterology. Supplement.

[20]  S. B. des Varannes,et al.  Symptoms and disease severity in gastro-oesophageal reflux disease. , 1994, Scandinavian journal of gastroenterology. Supplement.

[21]  J R Bennett,et al.  The endoscopic assessment of esophagitis: a progress report on observer agreement. , 1996, Gastroenterology.

[22]  A. Berstad,et al.  Endoscopic grading of reflux oesophagitis: what observations correlate with gastro-oesophageal reflux? , 1997, Scandinavian journal of gastroenterology.

[23]  J. Dent,et al.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. , 1998, Scandinavian journal of gastroenterology.

[24]  I. Wiklund,et al.  Gastro‐oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole , 1998 .

[25]  H. Hernqvist,et al.  One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. , 1998, Scandinavian journal of gastroenterology.